iFyber LLC proposal define a novel solution for the Point-of-Care diagnostics market. Traditional In-Vitro Diagnostic testing most often requires multiple steps (sample purification and analyte separation, analyte concentration/amplification, and detection) to achieve even qualitative levels of detection. iFyber proposes to develop and commercialize an entirely new paradigm in the POC diagnostic market that utilizes a unique microsphere-based, passive proximity assay (PPA) for integrated sample purification and target analyte capture, concentration and detection
Keywords: Clia,Sers,Microspheres,Spectroscopy,Nanocoatings,Assay,Diagnostics,Point-Of-Care
